cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen

DRUG2 trials

Sponsors

Alexion Pharmaceuticals, Inc.

Conditions

AL Amyloidosis

Phase 3

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

Active, not recruitingNCT04504825

Alexion Pharmaceuticals, Inc.AL Amyloidosis

Start: 2020-08-25End: 2027-10-22Updated: 2026-07-02

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

Active, not recruitingNCT04512235

Alexion Pharmaceuticals, Inc.AL Amyloidosis

Start: 2020-11-03End: 2027-04-08Updated: 2026-06-17

Related Papers

Phase 3 randomized trial to evaluate the impact of anselamimab on all-cause mortality in κ light-chain amyloidosis.

Journal of Clinical Oncology2026-05-28

Development of a high-affinity antibody specific to the predominant λ light chain amyloid subtype for AL amyloidosis immunotherapy

Blood2025-11-03

Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) Trial.

2024-07-11

Safety and Tolerability of Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia Therapy in Patients with Light-Chain Amyloidosis: 24-Month Results of a Phase 2 Study

Blood2023-11-024 citations

PB2150: CARDIAC AMYLOID REACHING FOR EXTENDED SURVIVAL (CARES) TRIALS: 2 PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, PHASE 3 TRIALS ASSESSING CAEL-101 IN PATIENTS WITH MAYO STAGES IIIA/IIIB AL AMYLOIDOSIS

HemaSphere2023-08-013 citations

Enrolling patients in Cardiac Amyloid Reaching for Extended Survival (CARES) trials: Two placebo-controlled, double-blind, randomized, international phase 3 trials assessing CAEL-101 in patients with Mayo stage IIIa or stage IIIb AL amyloidosis.

Journal of Clinical Oncology2023-06-014 citations

Cardiac Amyloid Reaching for Extended Survival (CARES): Study Design of Two Placebo-Controlled, Double-Blind, Randomized, International Phase 3 Trials Assessing Cael-101 in Patients with Mayo Stage Iiia or Stage IIIb AL Amyloidosis

Blood2021-11-058 citations

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis.

2021-02-034 citations